Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7666)
All Articles published online
|
Publishing Process of This Article
|
Aug 28, 2015 (publication date) through Feb 18, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Bouazza F, Poncelet A, Garcia CA, Delatte P, Engelhom JL, Galdon MG, Deleporte A, Hendlisz A, Vanderlinden B, Flamen P, Donckier V. Radioembolisation and portal vein embolization before resection of large hepatocellular carcinoma. World J Gastroenterol 2015; 21(32): 9666-9670 [PMID: 26327775 DOI: 10.3748/wjg.v21.i32.9666] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i32/9666.htm |
| Number | Citing Articles |
| 1 |
C.J. Isfordink, M. Samim, M.N.G.J.A. Braat, A.M. Almalki, J. Hagendoorn, I.H.M. Borel Rinkes, I.Q. Molenaar. Portal vein ligation versus portal vein embolization for induction of hypertrophy of the future liver remnant: A systematic review and meta-analysis. Surgical Oncology 2017; 26(3): 257 doi: 10.1016/j.suronc.2017.05.001
|
| 2 |
Pietro Addeo, Pierre de Mathelin, Pierre De Marini, Michel Greget, Philippe Bachellier. Sequential Y90 liver radioembolization and portal vein embolization: an additional strategy to downstage liver tumors and to enhance liver hypertrophy before major hepatectomies. Langenbeck's Archives of Surgery 2023; 408(1) doi: 10.1007/s00423-023-03083-0
|
| 3 |
Caren van Roekel, Margot T.M. Reinders, Sandra van der Velden, Marnix G.E.H. Lam, Manon N.G.J.A. Braat. Hepatobiliary Imaging in Liver-directed Treatments. Seminars in Nuclear Medicine 2019; 49(3): 227 doi: 10.1053/j.semnuclmed.2019.01.007
|
| 4 |
Clifford Akateh, Sylvester M Black, Lanla Conteh, Eric D Miller, Anne Noonan, Eric Elliott, Timothy M Pawlik, Allan Tsung, Jordan M Cloyd. Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma. World Journal of Gastroenterology 2019; 25(28): 3704-3721 doi: 10.3748/wjg.v25.i28.3704
|
| 5 |
Samuel D. Butensky, Kevin G. Billingsley, Sajid A. Khan. Reasonable expansion of surgical candidates for HCC treatment. Clinical Liver Disease 2024; 23(1) doi: 10.1097/CLD.0000000000000153
|
| 6 |
Emrullah Birgin, Erik Rasbach, Steffen Seyfried, Nils Rathmann, Steffen J. Diehl, Stefan O. Schoenberg, Christoph Reissfelder, Nuh N. Rahbari. Contralateral Liver Hypertrophy and Oncological Outcome Following Radioembolization with 90Y-Microspheres: A Systematic Review. Cancers 2020; 12(2): 294 doi: 10.3390/cancers12020294
|
| 7 |
Michael Vouche, Thierry Degrez, Fikri Bouazza, Philippe Delatte, Maria Gomez Galdon, Alain Hendlisz, Patrick Flamen, Vincent Donckier. Sequential tumor-directed and lobar radioembolization before major hepatectomy for hepatocellular carcinoma. World Journal of Hepatology 2017; 9(36): 1372-1377 doi: 10.4254/wjh.v9.i36.1372
|
| 8 |
I. Kurilova, V. Pompa, R. Guerrero, Mesa A. Tapias, Mizrrahi D. Calatayud, C. Fondevila, J. A. González, J. Duch, F. M. Gomez. 90Y-Radioembolization After Failed Portal Vein Embolization for Colorectal Liver Metastases: A Case Report. CardioVascular and Interventional Radiology 2020; 43(8): 1232 doi: 10.1007/s00270-020-02537-y
|
| 9 |
Benjamin P.T. Loveday, Arash Jaberi, Carol-Anne Moulton, Alice C. Wei, Steven Gallinger, Robert Beecroft, Sandra Fischer, Anand Ghanekar, Ian McGilvray, Gonazolo Sapisochin, Paul D. Greig, Kongteng Tan, Sean P. Cleary. Effect of portal vein embolization on treatment plan prior to major hepatectomy for hepatocellular carcinoma. HPB 2019; 21(8): 1072 doi: 10.1016/j.hpb.2018.12.009
|
| 10 |
Joseph W. Franses, Andrew X. Zhu. Neoadjuvant Approaches in Hepatocellular Carcinoma: There's No Time Like the Present. Clinical Cancer Research 2022; 28(13): 2738 doi: 10.1158/1078-0432.CCR-22-0025
|
| 11 |
Sonia T. Orcutt, Yazan Abuodeh, Arash Naghavi, Jessica Frakes, Sarah Hoffe, Bela Kis, Daniel A. Anaya. Kinetic analysis of contralateral liver hypertrophy after radioembolization of primary and metastatic liver tumors. Surgery 2018; 163(5): 1020 doi: 10.1016/j.surg.2017.11.020
|
| 12 |
Jonathan Charles, Nariman Nezami, Mohammad Loya, Samuel Shube, Cliff Davis, Glenn Hoots, Jamil Shaikh. Portal Vein Embolization: Rationale, Techniques, and Outcomes to Maximize Remnant Liver Hypertrophy with a Focus on Contemporary Strategies. Life 2023; 13(2): 279 doi: 10.3390/life13020279
|
| 13 |
Mégane Lemaire, Valerio Lucidi, Fikri Bouazza, Georgios Katsanos, Bruno Vanderlinden, Hugo Levillain, Philippe Delatte, Camilo A. Garcia, Michael Vouche, Maria Gomez Galdon, Pieter Demetter, Amélie Deleporte, Alain Hendlisz, Patrick Flamen, Vincent Donckier. Selective internal radiation therapy (SIRT) before partial hepatectomy or radiofrequency destruction for treatment of hepatocellular carcinoma in cirrhotic patients: a feasibility and safety pilot study. HPB 2018; 20(7): 641 doi: 10.1016/j.hpb.2018.01.006
|
| 14 |
M. N. G. J. A. Braat, M. Samim, M. A. A. J. van den Bosch, M. G. E. H. Lam. The role of 90Y-radioembolization in downstaging primary and secondary hepatic malignancies: a systematic review. Clinical and Translational Imaging 2016; 4(4): 283 doi: 10.1007/s40336-016-0172-0
|
| 15 |
Andreas Koulouris, Christos Tsagkaris, Vasiliki Spyrou, Eleni Pappa, Aikaterini Troullinou, Michail Nikolaou. Hepatocellular Carcinoma: An Overview of the Changing Landscape of Treatment Options. Journal of Hepatocellular Carcinoma 2021; : 387 doi: 10.2147/JHC.S300182
|
| 16 |
Iveta Urban, Florian Primavesi, Klaus Bogner, Claudia Bartsch, Marlene Trattner, Alexandra Schmid, Stefan Stättner. Hepatocellular carcinoma—neoadjuvant systemic and local treatment concepts to improve resectability rates and oncological outcome. memo - Magazine of European Medical Oncology 2022; 15(1): 5 doi: 10.1007/s12254-021-00791-5
|